Science and Research

LOng term usability of the self-injecTion with the mepolizumab aUtoinjector or prefilled Syringe

Describe overall treatment satisfaction with Nucala autoinjector / prefilled syringe
at the 6 and 12 months documentation with a verbal rating (Likert) scale and at
baseline and at the 6 and 12 months documentation with the ITAQ (Injection
Treatment Acceptance Questionnaire)

Study details
DZL Disease Area: AA
Study Type: Observational
DZL Role: DZL recruiting center
Funding: Externally - industry
DZL Participating Sites: BREATH
Start Date: 06.12.2021
Completion Date: 31.12.2025
Status: Closed


chevron-down